Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population
Authors
Keywords
Prostate cancer detection, Prostate health index, mpMRI, PI-RADS
Journal
WORLD JOURNAL OF UROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-22
DOI
10.1007/s00345-019-02889-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
- (2018) Sasha C. Druskin et al. BJU INTERNATIONAL
- Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate Cancer
- (2018) Wulphert Venderink et al. EUROPEAN UROLOGY
- Epidemiology of prostate cancer in Asian countries
- (2018) Takahiro Kimura et al. INTERNATIONAL JOURNAL OF UROLOGY
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings
- (2018) Peter K.-F. Chiu et al. EUROPEAN UROLOGY
- Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis
- (2017) Sungmin Woo et al. EUROPEAN UROLOGY
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China
- (2017) Rong Na et al. PROSTATE
- Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice
- (2017) J J Tosoian et al. PROSTATE CANCER AND PROSTATIC DISEASES
- ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study
- (2017) I Heidegger et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Measurement of serum isoform [–2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2–10 ng/ml
- (2017) Kazuhiro Furuya et al. Scandinavian Journal of Urology
- Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer
- (2016) Stacy Loeb et al. BJU INTERNATIONAL
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
- (2016) Jeffrey C. Weinreb et al. EUROPEAN UROLOGY
- Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR
- (2016) Andrew B. Rosenkrantz et al. JOURNAL OF UROLOGY
- The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population
- (2016) V. J. Gnanapragasam et al. Scientific Reports
- Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
- (2015) Jurgen J. Fütterer et al. EUROPEAN UROLOGY
- Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis
- (2015) Ivo G. Schoots et al. EUROPEAN UROLOGY
- Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men
- (2015) Claire de la Calle et al. JOURNAL OF UROLOGY
- The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
- (2015) Stacy Loeb et al. JOURNAL OF UROLOGY
- Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group
- (2013) Caroline M. Moore et al. EUROPEAN UROLOGY
- A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial
- (2013) James S. Wysock et al. EUROPEAN UROLOGY
- Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Diagnostic significance of [−2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0–10.0 ng/mL range
- (2012) Kazuto Ito et al. WORLD JOURNAL OF UROLOGY
- Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer
- (2011) Alessandro Sciarra et al. EUROPEAN UROLOGY
- Pre-analytical in-vitro stability of [-2]proPSA in blood and serum
- (2010) Axel Semjonow et al. CLINICAL BIOCHEMISTRY
- Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
- (2010) Flip H. Jansen et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More